You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
Type 2 Inflammation

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join experts Mario Castro, Nicola Hanania, and Stephanie Christenson for an educational symposium on the real-world impact of underlying type 2 inflammation on the patient burden of asthma and COPD.

Mario Castro
Nicola A. Hanania
Stephanie  Christenson
MD, MPH
Mario Castro +2 more
20May2024
Begins in
Location
Manchester Grand Hyatt San Diego
San Diego, CA United States

Learning objectives

  • Understand the shared and unique disease burden in COPD with type 2 inflammation and moderate-to-severe asthma​​
  • Identify the role of type 2 inflammation in the pathophysiology of moderate-to-severe asthma and COPD with type 2 inflammation​​
  • Differentiate between the clinical manifestations of type 2 inflammation in moderate-to-severe asthma and COPD with type 2 inflammation using real-world patient cases​

Description

Join the ADVENT program at the ATS 2024 conference in San Diego for an educational symposium on the shared and unique pathophysiological features of type 2 inflammation-driven asthma and COPD and their real-world impact on patients. 

Don't miss your opportunity to hear directly from global experts in pulmonology during the live audience Q&A following the presentations. 

Agenda

Welcome and Introductions

Mario Castro (Chair)

Patient Burden and Airway Remodeling in Asthma

Nicola Hanania

COPD with Type 2 Inflammation: Patient Burden and Fixed Airway Obstruction

Stephanie Christenson

Overview of Type 2 Inflammation in Airway

Mario Castro 

Panel Discussion:  Airway Inflammation - Burden and Outcome

All Faculty

Q&A

All Faculty

 

Location
Manchester Grand Hyatt San Diego
San Diego, CA United States
MAT-US-2402773 -P V1.0 - 05/22/2024

Speakers

Related resources